- Advertisement -spot_img

TAG

anti-cancer

Celltrion releases biosimilar Vegzelma in U.S.

Celltrion Healthcare, a Korean pharmaceuticals company, said Monday that it has launched its anti-cancer biosimilar Vegzelma in the United States. The bevacizumab treatment, a biosimilar...

Latest news

- Advertisement -spot_img